Suppr超能文献

WY-49605与其他六种口服制剂的抗菌活性比较及纸片扩散法药敏试验中纸片含药量的选择

Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing.

作者信息

Fuchs P C, Barry A L, Sewell D L

机构信息

St. Vincent Hospital and Medical Center, Portland, Oregon 97225, USA.

出版信息

Antimicrob Agents Chemother. 1995 Jul;39(7):1472-9. doi: 10.1128/AAC.39.7.1472.

Abstract

The in vitro antimicrobial activity of an oral penem, WY-49605, was compared with those of six other oral antimicrobial agents against 598 bacterial isolates representing 51 different species. WY-49605 exhibited good activity against most gram-positive bacteria and members of the family Enterobacteriaceae. It had little activity against nonfermenting gram-negative bacilli, Enterobacter spp., Serratia spp., enterococci, Staphylococcus haemolyticus, and methicillin-resistant Staphylococcus aureus. Its activity was unaffected by the beta-lactamases of Neisseria gonorrhoeae, Haemophilus influenzae, and staphylococci. Disk diffusion susceptibility tests were performed with 5-, 10-, 15-, and 30-micrograms WY-49605 disks. The 5-micrograms disk is recommended, with tentative breakpoints of > or = 16 mm for susceptibility (MIC, < or = 2.0 microgram/ml) and < or = 12 mm for resistance (MIC, > or = 8.0 micrograms/ml).

摘要

将一种口服青霉烯类药物WY - 49605的体外抗菌活性与其他六种口服抗菌药物针对代表51个不同菌种的598株细菌分离株的抗菌活性进行了比较。WY - 49605对大多数革兰氏阳性菌和肠杆菌科成员表现出良好的活性。它对非发酵革兰氏阴性杆菌、肠杆菌属、沙雷氏菌属、肠球菌、溶血葡萄球菌和耐甲氧西林金黄色葡萄球菌几乎没有活性。其活性不受淋病奈瑟菌、流感嗜血杆菌和葡萄球菌的β - 内酰胺酶影响。使用含5微克、10微克、15微克和30微克WY - 49605的药敏纸片进行纸片扩散法药敏试验。推荐使用5微克的药敏纸片,初步判断标准为:敏感(MIC,≤2.0微克/毫升)时抑菌圈直径≥16毫米,耐药(MIC,≥8.0微克/毫升)时抑菌圈直径≤12毫米。

相似文献

3
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):495-510. doi: 10.1016/0732-8893(89)90084-9.
4
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Diagn Microbiol Infect Dis. 1987 Mar;6(3):185-92. doi: 10.1016/0732-8893(87)90011-3.
6
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Antimicrob Agents Chemother. 1994 Sep;38(9):1974-9. doi: 10.1128/AAC.38.9.1974.
8
In-vitro activity of a new penem FCE 22101.
J Antimicrob Chemother. 1989 Mar;23 Suppl C:53-7. doi: 10.1093/jac/23.suppl_c.53.

引用本文的文献

1
Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant and .
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0012522. doi: 10.1128/aac.00125-22. Epub 2022 Jun 1.
2
Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2002 Aug;46(8):2696-9. doi: 10.1128/AAC.46.8.2696-2699.2002.
4
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Antimicrob Agents Chemother. 2001 Jul;45(7):1964-71. doi: 10.1128/AAC.45.7.1964-1971.2001.

本文引用的文献

1
Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
J Antibiot (Tokyo). 1989 Jun;42(6):977-88. doi: 10.7164/antibiotics.42.977.
2
Susceptibility of anaerobic bacteria to ALP 201.
Antimicrob Agents Chemother. 1989 Dec;33(12):2137-9. doi: 10.1128/AAC.33.12.2137.
3
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):919-24. doi: 10.1007/BF01963784.
4
Comparative antibacterial activity of the penem ALP 201.
Chemotherapy. 1991;37(6):413-9. doi: 10.1159/000238888.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验